Literature DB >> 18209365

Renal failure in multiple myeloma "the myeloma kidney":state of the art.

H Goldschmidt1, H Lannert, J Bommer, A D Ho.   

Abstract

Renal failure is present in about 20% of patients with multiple myeloma (MM) at diagnosis. Renal function impairment is usually caused by the so-called "myeloma kidney" and is associated with shortened survival in patients treated with conventional therapy. Renal failure is reversible in up to 50% of patients, particularly when its degree is moderate and it is related to precipitating factors such as hypercalcemia. In our experience, approximately 10% of newly diagnosed patients with MM have renal failure severe enough to require dialysis. Despite its frequency, there are few reports dealing with MM and renal failure.

Entities:  

Year:  2001        PMID: 18209365

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  2 in total

1.  An unusual association of autosomal polycystic kidney disease and multiple myeloma.

Authors:  Sanjay Kumar Mandal; Jacky Ganguly; Soumya Sarathi Mondal; Koelina Sil
Journal:  BMJ Case Rep       Date:  2014-01-13

2.  Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment.

Authors:  Dao-bin Zhou; Li Yu; Xin Du; Jie Jin; Zhen Cai; Fangping Chen; Xiaoyan Ke; Xiao Li; Depei Wu; Fanyi Meng; Huisheng Ai; Jingshan Zhang; Dena DeMarco; Nianhang Chen; Jay Mei; Jianmin Wang; Jian Hou
Journal:  Int J Hematol       Date:  2015-03-10       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.